Veterinary Vaccines Market Size, Share, Growth Analysis, By Disease, By Technology, By Type, By Route of Administration, By Region-Industry Forecast 2024-2031

Description

Global Veterinary vaccines market size was valued at USD 8.00 billion in 2022 and is poised to grow from USD 8.50 billion in 2023 to USD 13.75 billion by 2031, at a CAGR of 6.2% during the forecast period (2024-2031).

The escalating prevalence of zoonotic diseases, driven by factors such as population growth, intensive agriculture, and climate change, has underscored the critical role of animal vaccines in safeguarding both human and animal health. These diseases pose significant risks to food security, public health, and economic stability. As a result, the development and deployment of effective animal vaccines have become imperative to prevent the spread of infectious diseases and protect vulnerable populations. The pharmaceutical industry is investing heavily in research and development to address this growing challenge and develop innovative vaccine solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Vaccines Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Vaccines Market Segmental Analysis

Global veterinary vaccines market is segmented based on disease, technology, type, route of administration, distribution channel, and region. Based on disease the market is segmented into livestock diseases (bovine diseases and small ruminant diseases), poultry diseases, porcine diseases, companion animal diseases (canine diseases and feline diseases) and aquaculture diseases. Based on Technology the market is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other. Based on Type the market is segmented into livestock vaccines (bovine diseases and small ruminant diseases), poultry vaccines, companion animal vaccines (canine vaccines and feline vaccines), porcine vaccines, aquaculture vaccines. Based on route of administration the market is segmented into injectable vaccines, oral vaccines and intranasal/spray vaccines. Based on distribution channel the market is segmented into veterinary hospitals, veterinary clinics, and retail pharmacies. Based on region the global Veterinary vaccines Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Veterinary Vaccines Market

The surge in global meat consumption, driven by rising incomes and changing dietary habits, is a primary catalyst for the growth of the veterinary vaccines market. The expanding livestock industry, particularly in developing economies, has led to increased disease prevalence, emphasizing the critical role of vaccination in maintaining animal health and productivity. As consumers become more aware of food safety and animal welfare, the demand for safe and high-quality animal products is growing, further bolstering the importance of preventive healthcare measures, including vaccination.

Restraints in the Global Veterinary Vaccines Market

The development of animal vaccines is a complex and costly endeavor. The high cost of research and development, coupled with the lengthy regulatory approval process, presents significant challenges for pharmaceutical companies. Diseases like African Swine Fever and Foot and Mouth Disease require substantial investments in time and resources to develop effective vaccines. Additionally, the need for continuous innovation to address evolving pathogens further increases the financial burden on the industry. These factors contribute to the overall cost of animal vaccines, impacting their accessibility and affordability for livestock producers.

Market Trends of the Global Veterinary Vaccines Market

The surge in global meat consumption, driven by rising incomes and population growth, is a primary catalyst for the veterinary vaccines market. The expanding livestock industry, particularly in developing economies, has led to increased disease prevalence, emphasizing the critical role of vaccination in maintaining animal health and productivity. As consumers become more conscious of food safety and animal welfare, the demand for safe and high-quality animal products is driving the adoption of preventive healthcare measures, including vaccination.

Product Code: SQMIG35I2239

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors of The Market
Value Chain Analysis
Top Investment Pockets
Market Attractive Index
Ecosystem Mapping
Technology Analysis
Supply Chain Analysis
Patent Analysis
Porter's Five Forces Analysis
Indicative Pricing Model Analysis
Industry Trends
Regulatory Analysis
Key Stakeholder and Buying Criteria

Veterinary Vaccine Market by Diseases

Market Overview
Livestock Diseases
- Bovine Diseases
- Small Ruminant Disease
Porcine Diseases
Poultry Diseases
Companion Diseases
- Canine Diseases
- Feline Diseases
Aquaculture Diseases

Veterinary vaccines Market by Technology

Market Overview
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other

Veterinary vaccines Market by Type

Market Overview
Livestock vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
Poultry vaccines
Companion Animal vaccines
- Canine Vaccines
- Feline Vaccines
Aquaculture vaccines
Other

Veterinary vaccines Market by Route of Administration

Market Overview
Injectable Vaccines
Oral Vaccines
Intranasal/Spray Vaccines

Veterinary vaccines Market by Distribution Channel

Market Overview
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies

Veterinary vaccines Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Zoetis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phibro Animal Health Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hester Biosciences Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HIPRA (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tianjin Ringpu Bio-Technology Co Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jinyu Bio-technology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vaxxinova International BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endovac Animal Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brilliant Bio Pharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptimmune (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Torigen Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VEROVACCiNES GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intas Pharmaceuticals (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ourofino Animal Health (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovac (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratoire LCV (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments